We create and publish training materials and deal with the research of financial and commodity markets and identification of trading opportunities. We create information content in digital electronic form and its subsequent sale. We are not a stockbroker or broker, we are not financial institutions and we are not a financial intermediary.

21/1/20 9:57(CET)_Inovio Pharmaceuticals_LONG

Inovio Pharmaceuticals Long. Inovio Pharmaceuticals is one of many pharmaceutical companies running a drug race at Covid19. Currently, the market has moved upwards, confirming the positive mood of investors, due to the conclusion of an agreement between Inovio and Advaccine on a license agreement for the production and sale of the INO-4800 vaccine in China. And there is no bigger market than China. CA analysts expect a gradual rise in price, taking into account the average volatility to values around $ 20 per CFD, a share.

Chart source: WebTrader


Add comment

Your email address will not be published. Required fields are marked *

Your personal data will only be used for the processing of this comment. Principles of personal data processing